This inventor holds 2 USPTO granted patents. Top assignee: Ecole Polytechnique Federale De Lausanne. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Paul McLaren: Innovator in Privacy-Preserving Medical Technologies
Introduction
Paul McLaren is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical technology, particularly in privacy-preserving methods for medical testing. With a total of 2 patents, McLaren is at the forefront of innovations that enhance patient privacy while utilizing genomic data.
Latest Patents
McLaren's latest patents include a "Method for privacy-preserving medical risk test" and "Privacy-enhancing technologies for medical tests using genomic data." The first patent describes a privacy-preserving method for performing a disease susceptibility test on a patient. This method also relates to inferring ancestry in the encrypted domain. The second patent proposes privacy-enhancing technologies for medical tests and personalized medicine methods that utilize patients' genomic data. It involves storing genomic data encrypted by a patient's public keys at a Storage and Processing Unit (SPU), ensuring that patient privacy is maintained throughout the testing process.
Career Highlights
Paul McLaren is affiliated with the École Polytechnique Fédérale de Lausanne, where he contributes to research and development in medical technologies. His work focuses on integrating privacy measures into medical testing, which is crucial in today's data-driven healthcare environment.
Collaborations
Some of McLaren's notable coworkers include Jean Louis Raisaro and Erman Ayday. Their collaborative efforts contribute to advancing the field of privacy-preserving medical technologies.
Conclusion
Paul McLaren is a pioneering inventor whose work in privacy-preserving medical technologies is shaping the future of healthcare. His innovative patents reflect a commitment to enhancing patient privacy while utilizing advanced genomic data.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
